The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Simon Rule | EHA 2018 | What are the key findings of the acalabrutinib study in patients with WM?

Jun 18, 2018

23rd Congress of the European Hematology Association, 14-17 June 2018, Stockholm, Sweden
Simon Rule
Derriford Hospital, Plymouth Hospitals NHS Trust, Plymouth, UK

Interview topic: What are the key findings of the acalabrutinib study in patients with WM?

Simon Rule | EHA 2018 | What are the key findings of the acalabrutinib study in patients with WM?